Skip to main content
. 2021 Dec 29;23(1):355. doi: 10.3390/ijms23010355

Figure 3.

Figure 3

Ibrutinib did not reduce CD45RA-positive B cell population after SCI Injury. Flow cytometry analysis of splenic samples showed that there were no differences in CD45RA-positive B cell population between Ibrutinib-treated and vehicle-treated injured or sham-operated animals at 1-week post-injury. Anti-CD45RA-PE antibody was specific for the rat CD45RA-B cells. Data are presented as mean ± S.E.M., n = 4 per group, and analyzed with one-way ANOVA followed by Bonferroni post hoc analysis.